Hong Kong stocks soar | Sansheng Pharmaceuticals (01530.HK) rises by over 3% again. Institutions state that the initiation of the 707 project's global clinical trials is expected to become an important catalyst for the company's profit growth.
According to the Wisdom Financial APP, Sanlife Pharmaceutical (01530.HK) rose by over 3% again. As of the time of writing, it increased by 3.61% to HK$32.16, with a trading volume of HK$5.84 billion.
Latest
